Clinical Trial Update: A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, and select low-grade lymphomas;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• ZE50-0134

Snippet

Sponsor: Lomond Therapeutics Holdings, Inc. | Conditions: CLL / SLL, CLL (Chronic Lymphocytic Leukemia) | Phase 1 | Status: RECRUITING